| Annual Financials | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 89 | 68 | 77 | 102 | 0 |
| Expenses | 78 | 60 | 57 | 71 | 0 |
| EBITDA | 11 | 8 | 20 | 31 | 0 |
| Operating Profit % | 12 % | 11 % | 25 % | 30 % | 0 % |
| Depreciation | 1 | 1 | 1 | 1 | 0 |
| Interest | 0 | 2 | 2 | 3 | 0 |
| Profit Before Tax | 10 | 5 | 16 | 27 | 0 |
| Tax | 3 | 1 | 4 | 7 | 0 |
| Net Profit | 8 | 3 | 12 | 20 | 0 |
| EPS in ₹ | 5.07 | 2.27 | 8.06 | 9.46 | 0.00 |
KRM Ayurveda
KRM Ayurveda
239.95
+7.95
(3.43%)
Market Cap
510.15 Cr
PE Ratio
-
Volume
69,000.00
Day High - Low
241.00 - 232.00
52W High-Low
271.00 - 156.15
Key Fundamentals
Market Cap
510.15 Cr
EPS
9.46
PE Ratio
-
PB Ratio
4.10
Book Value
56.55
EBITDA
30.50
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
50.67
Debt to Equity
1.52
Actual
Company News
View All News
KRM Ayurveda files FY26 earnings call transcript with NSE, reporting ₹10,169.07 Lakh revenue, 32.84% YoY growth, ₹2,012 Lakh PAT, and plans 30 clinics and 500-bed expansion.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,863.20 | #1 4,47,044.09 | 39.96 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 63.20 | |
6,921.50 | 1,83,744.08 | 72.74 | 9,712.00 | 18.67 | 2,191 | -1.02 | 76.54 | |
4,403.90 | 1,49,047.99 | 63.98 | 11,539.40 | 6.99 | 1,911 | 26.24 | 58.43 | |
1,436.70 | 1,16,053.85 | 27.76 | 27,711.70 | -2.46 | 3,783 | -55.32 | 70.81 | |
1,303.60 | 1,08,804.06 | 25.40 | 33,593.30 | -0.44 | 3,998 | -86.05 | 54.59 | |
2,258.20 | 1,03,209.50 | 18.91 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 43.90 | |
2,462.20 | 1,01,640.86 | 55.11 | 12,744.20 | 20.90 | 2,007 | 7.65 | 70.95 | |
991.70 | 99,788.22 | #1 18.80 | 23,511.00 | 18.55 | 4,615 | -0.32 | 66.36 | |
1,510.90 | 87,753.32 | 24.96 | 32,345.60 | 9.43 | 3,484 | 7.59 | 73.72 | |
1,315.50 | 71,018.13 | 77.65 | 6,812.90 | #1 21.03 | 884 | 21.18 | 79.66 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
32.24 %
Net Income Growth
64.13 %
Cash Flow Change
96.63 %
ROE
74.91 %
ROCE
107.73 %
EBITDA Margin (Avg.)
17.59 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 40 | 44 | 67 | 122 |
| Fixed Assets | 23 | 23 | 27 | 26 |
| Current Assets | 16 | 21 | 39 | 94 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 9 |
| Other Assets | 16 | 21 | 40 | 0 |
| Total Equity & Liabilities | 40 | 44 | 67 | 122 |
| Current Liabilities | 13 | 11 | 24 | 7 |
| Non Current Liabilities | 18 | 21 | 19 | 1 |
| Total Equity | 8 | 12 | 24 | 115 |
| Reserve & Surplus | 8 | 12 | 24 | 93 |
| Share Capital | 0 | 0 | 0 | 21 |
Cash Flow
| Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 2 |
| Investing Activities | -23 | -0 | -4 |
| Operating Activities | 4 | -1 | 0 |
| Financing Activities | 20 | 1 | 6 |
Share Holding
| % Holding | Sept 2025 | Jan 2026 | Mar 2026 |
| Promoter | 92.16 % | 92.16 % | 69.15 % |
| FIIs | 0.00 % | 0.00 % | 3.86 % |
| DIIs | 0.00 % | 0.00 % | 3.34 % |
| Government | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 14.87 % |
| Others | 7.84 % | 7.84 % | 8.78 % |
| No of Share Holders | 54 | 64 | 536 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 01 May 2026 |  Quarterly Result Announcement | NA | 01 May 2026 | 214.00 | 236.50 |
Technical Indicators
RSI(14)
Neutral 50.79
ATR(14)
Less Volatile 13.90
STOCH(9,6)
Neutral 57.85
STOCH RSI(14)
Oversold 5.64
MACD(12,26)
Bearish -1.27
ADX(14)
Strong Trend 26.34
UO(9)
Bearish 46.45
ROC(12)
Uptrend And Accelerating 3.83
WillR(14)
Neutral -70.40
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
